Chairman of the Board
Mr. Duncan has more than 20 years of healthcare and life sciences experience including senior commercial, strategy and general management roles at GlaxoSmithKline, IVAX Pharmaceuticals, and Healthcare at Home. Prior to accepting the interim Chief Executive Officer role at Concordia International Corp., Mr. Duncan previously served as President of Concordia’s International segment since January 2016. Prior to his role as President, he was Managing Director for Concordia’s International segment.
Mr. Fishman has approximately 20 years of experience as a business leader, including his recent role as CEO of specialty pharmaceutical company Merus Labs International Inc. (TSX: MSL, NASDAQ: MSLI). In July 2017, European speciality pharmaceutical company Norgine B.V. acquired Merus Labs. His leadership history also includes serving as CEO of Teva Canada for six years, and prior to that, he served as Taro Canada’s CEO. He is also a past Chair of the Canadian Generic Manufacturers Association. Mr. Fishman began his pharmaceutical career at Eli Lilly and spent 17 years at the company in increasingly senior roles. He is currently the CEO of VIVO Cannabis Inc. (TSX-V: VIVO), a licensed producer and distributor of premium pharmaceutical-grade plant-based medicines.
Mr. Hager is a Principal at GSO Capital Partners based in London, England. He is involved in both debt and equity investments across a wide variety of industries with a specific focus on special situations. Before joining GSO Capital Partners, Mr. Hager worked in Blackstone’s Restructuring & Reorganization Group where he advised debtors and creditors on in-court and out-of-court restructurings. Prior to Blackstone, Mr. Hager worked at Lehman Brothers and Nomura International in London where he was involved in numerous transactions across the industrial and technology sectors including mergers and acquisitions, initial public offerings and leveraged buyouts.
Mr. Manzo co-founded Policano and Manzo, LLC, a consulting firm specializing in providing financial services to distressed companies and their lenders. In 2000, Mr. Manzo sold his firm to FTI Consulting, Inc., a global business advisory firm where he held the position of senior managing director through 2005. Since 2006, Mr. Manzo has been a private investor and serves on a number of public and private company boards.